Paperpal Prime Logo

Medicines : Impact Factor & More

eISSN: 2305-6320
JournalOpen Access

Key Metrics

Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Medicines

Medicines Journal Specifications

Indexed in the following public directories

  • DOAJ DOAJ
Overview
Publisher MDPI AG
Language English
Article Processing ChargesCHF 1400
Publication Time6
Editorial Review ProcessBlind peer review
General Details
LanguageEnglish
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 6
Editorial Review Detail
Editorial TeamVisit website
Review ProcessBlind peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Medicines ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Medicines

Correction: Nasser et al. Potency of Combining Eucalyptus camaldulensis subsp. camaldulensis with Low-Dose Cisplatin in A549 Human Lung Adenocarcinomas and MCF-7 Breast Adenocarcinoma. Medicines 2020, 7, 40
  • 14 Jul 2026
  • Medicines
FDA-Approved Drugs Containing Amide Functionality in the Last Five Years (2021\u20132025): Pharmaceutical Use, Trends and Synthetic Approaches
  • 7 Jul 2026
  • Medicines
Beyond Weight Loss: Early Real-World Evidence of Semaglutide in Obesity
  • 28 Jun 2026
  • Medicines
Cinnamon-Derived Compounds Reduce PD-L1 Expression in UV-Exposed Human Skin Cell Line.
  • 20 Jun 2026
  • Medicines (Basel, Switzerland)
Narrative Review of Novel Nicotine-Delivery Systems and Emerging Pharmaceuticals for Tobacco Cessation.
  • 12 Jun 2026
  • Medicines (Basel, Switzerland)
Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia-Guidelines and Recent Developments.
  • 30 May 2026
  • Medicines (Basel, Switzerland)
Correction: Nasser et al. Potency of Combining Eucalyptus camaldulensis subsp. camaldulensis with Low-Dose Cisplatin in A549 Human Lung Adenocarcinomas and MCF-7 Breast Adenocarcinoma. Medicines 2020, 7, 40
  • 14 Jul 2026
  • Medicines
FDA-Approved Drugs Containing Amide Functionality in the Last Five Years (2021\u20132025): Pharmaceutical Use, Trends and Synthetic Approaches
  • 7 Jul 2026
  • Medicines
Beyond Weight Loss: Early Real-World Evidence of Semaglutide in Obesity
  • 28 Jun 2026
  • Medicines
Cinnamon-Derived Compounds Reduce PD-L1 Expression in UV-Exposed Human Skin Cell Line.
  • 20 Jun 2026
  • Medicines (Basel, Switzerland)
Narrative Review of Novel Nicotine-Delivery Systems and Emerging Pharmaceuticals for Tobacco Cessation.
  • 12 Jun 2026
  • Medicines (Basel, Switzerland)
Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia-Guidelines and Recent Developments.
  • 30 May 2026
  • Medicines (Basel, Switzerland)

FAQs on Medicines